Biohaven (BHVN) Other financing activities (2021 - 2025)

Biohaven has disclosed Other financing activities across 5 years of filings, most recently posting $1.7 million for Q4 2025.

• Other financing activities for Q4 2025 came in at $1.7 million, up 1671.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 82.47% YoY), and the FY2025 annual result was $1.7 million, down 21.07% from the prior year.
• Other financing activities came in at $1.7 million for Q4 2025 at Biohaven, up from -$108000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $449.1 million in Q4 2022 to a low of -$1.1 million in Q4 2023.
• The 5-year median for Other financing activities is $1.5 million (2024), against an average of $53.3 million.
• Across the five-year window, Other financing activities jumped 113803.8% in 2022 and plunged 100.24% in 2023, its largest moves.
• Biohaven's Other financing activities stood at -$395000.0 in 2021, then surged by 113803.8% to $449.1 million in 2022, then sank by 100.24% to -$1.1 million in 2023, then jumped by 89.78% to -$108000.0 in 2024, then jumped by 1671.3% to $1.7 million in 2025.
• The last three Other financing activities figures came in at $1.7 million (Q4 2025), -$108000.0 (Q4 2024), and $1.5 million (Q3 2024), per Business Quant data.